CVS Health Corp (CVS · NYSE)

CVS · MARKET VIEW

Market view · as of Aug 31, 2026

Revenue (TTM)
$412.64B
+7.1% YoY
Gross margin
13.6%
EPS (latest q)
$2.58
vs $1.87 est · beat
52-wk position
59.7%
-15.3% vs 52w high · -10.9% 1mo

Price (last ~year)

CVS Health Corp reported second-quarter 2026 revenue of $106.10 billion and net income of $3.00 billion, reflecting a 188.8% year-over-year earnings increase. The company has surpassed analyst earnings estimates for four consecutive quarters while maintaining a market capitalization of $119.02 billion against $76.31 billion in total debt. Institutional investors, including Jupiter Topco LLC and Primecap Management, recently disclosed new positions in the company.

Valuation

Market cap
$119.02B
P/E
24.49
PEG
0.25
P/B
1.491
P/S
0.288
EV/EBITDA
13.51
Beta
0.596
Analyst target
$116.08

Quality & returns

Gross margin
13.6%
Operating margin
3.9%
Profit margin
1.2%
ROE
6.2%
ROA
3.0%

Price movement

Last
$93.06
1-month
-10.9%
3-month
+2.5%
RSI (14)
42
vs SMA200
+9.3%
52-wk position
59.7% -15.3% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-06-30$106.10B$4.70B$3.00B$5.86B
2026-03-31$100.43B$4.68B$2.94B$5.83B
2025-12-31$105.69B$2.11B$2.94B$3.29B
2025-09-30$102.87B$-3.21B$-3.98B$-1.56B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots